TY - JOUR T1 - Development and Validation of a Highly Generalizable Deep Learning Pulmonary Embolism Detection Algorithm JF - medRxiv DO - 10.1101/2020.10.09.20210112 SP - 2020.10.09.20210112 AU - Ryan Schmid AU - Jacob Johnson AU - Jennifer Ngo AU - Christine Lamoureux AU - Brian Baker AU - Lawrence Ngo Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/11/2020.10.09.20210112.abstract N2 - Several algorithms have been developed for the detection of pulmonary embolism, though generalizability and bias remain potential weaknesses due to small sample size and sample homogeneity. We developed and validated a highly generalizable deep-learning algorithm, Emboleye, for the detection of PE by using a large and diverse dataset, which included 30,574 computed tomography (CT) exams sourced from over 2,000 hospital sites. On angiography exams, Emboleye demonstrates an AUROC of 0.79 with a specificity of 0.99 while maintaining a sensitivity of 0.37 and PPV of 0.77. On non-angiography CT exams, Emboleye demonstrates an AUROC of 0.77 with a specificity of 0.99 while maintaining a sensitivity of 0.18 and PPV of 0.35.Competing Interest StatementLawrence Ngo and Jacob Johnson own a large proportion of shares in CoRead AI. Lawrence Ngo and Christine Lamoureux both work as radiologists for Virtual Radiologic. Brian Baker is an employee of Virtual Radiologic.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The reserach was approved with a waiver of consent by Western IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data from this manuscript is proprietary and not publically available. ER -